Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000892917-13-000011
Filing Date
2013-06-03
Accepted
2013-06-03 18:39:31
Documents
1
Period of Report
2013-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5275
  Complete submission text file 0000892917-13-000011.txt   6703
Mailing Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035
Business Address 5 CENTERPOINTE DRIVE, SUITE 400 LAKE OSWEGO OR 97035 971-2040382
CYTODYN INC (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: CO | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address MAGNETKAMERAN MR AB, SKEPPSBRON 28 STOCKHOLM V7 S-111 30
Business Address
Nobel Michael (Reporting) CIK: 0001307543 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 13889239